Literature DB >> 6238614

Pathological findings after percutaneous transluminal coronary angioplasty.

K Mizuno, A Kurita, N Imazeki.   

Abstract

Ten serial pathological cross sections at 1 mm intervals of both the left anterior descending artery at the site of a percutaneous transluminal coronary angioplasty and of the circumflex artery in the untreated stenotic area were studied at necropsy in a patient who died immediately after the procedure. The extent of calcification and atheroma were similar in both branches. Intimal or medial splitting, desquamation, and plaque fracture were present in the left anterior descending artery. No typical pathological findings were seen in the circumflex artery. This study suggests that the original stenotic lumen may have been enlarged as a result of plaque splitting.

Entities:  

Mesh:

Year:  1984        PMID: 6238614      PMCID: PMC481686          DOI: 10.1136/hrt.52.5.588

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  11 in total

1.  Frequency in nonangioplasty patients of morphologic findings reported in coronary arteries treated with transluminal angioplasty.

Authors:  J M Isner; R V Fortin
Journal:  Am J Cardiol       Date:  1983-03-01       Impact factor: 2.778

2.  Morphology after transluminal angioplasty in human beings.

Authors:  P C Block; R K Myler; S Stertzer; J T Fallon
Journal:  N Engl J Med       Date:  1981-08-13       Impact factor: 91.245

3.  Transluminal coronary angioplasty of postmortem human hearts.

Authors:  K L Baughman; R C Pasternak; J T Fallon; P C Block
Journal:  Am J Cardiol       Date:  1981-12       Impact factor: 2.778

4.  Transluminal dilatation of coronary-artery stenosis.

Authors:  A Gruntzig
Journal:  Lancet       Date:  1978-02-04       Impact factor: 79.321

5.  The mechanism of balloon angioplasty.

Authors:  W R Castaneda-Zuniga; A Formanek; M Tadavarthy; Z Vlodaver; J E Edwards; C Zollikofer; K Amplatz
Journal:  Radiology       Date:  1980-06       Impact factor: 11.105

6.  Acute effects of transluminal angioplasty in three experimental models of atherosclerosis.

Authors:  D P Faxon; V J Weber; C Haudenschild; S B Gottsman; W A McGovern; T J Ryan
Journal:  Arteriosclerosis       Date:  1982 Mar-Apr

7.  Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty.

Authors:  A R Grüntzig; A Senning; W E Siegenthaler
Journal:  N Engl J Med       Date:  1979-07-12       Impact factor: 91.245

8.  Transluminal angioplasty: correlation of morphologic and angiographic findings in an experimental model.

Authors:  P C Block; K L Baughman; R C Pasternak; J T Fallon
Journal:  Circulation       Date:  1980-04       Impact factor: 29.690

9.  Evaluation of transluminal angioplasty of chronic coronary artery stenosis. Value and limitations assessed in fresh human cadaver hearts.

Authors:  G Lee; R M Ikeda; J A Joye; H G Bogren; A N DeMaria; D T Mason
Journal:  Circulation       Date:  1980-01       Impact factor: 29.690

10.  Transluminal angioplasty in experimental atherosclerosis. Analysis for embolization using an in vivo perfusion system.

Authors:  T A Sanborn; D P Faxon; D Waugh; D M Small; C Haudenschild; S B Gottsman; T J Ryan
Journal:  Circulation       Date:  1982-11       Impact factor: 29.690

View more
  8 in total

Review 1.  Restenosis after angioplasty.

Authors:  A H Gershlick; D P de Bono
Journal:  Br Heart J       Date:  1990-12

2.  Pathological changes induced by repeated percutaneous transluminal coronary angioplasty.

Authors:  M Ueda; A E Becker; T Fujimoto
Journal:  Br Heart J       Date:  1987-12

Review 3.  Current place of coronary angioplasty.

Authors:  N P Silverton
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-30

Review 4.  Coronary angioplasty.

Authors:  I C Cooper; M Signy; M M Webb-Peploe; D J Coltart
Journal:  Postgrad Med J       Date:  1987-05       Impact factor: 2.401

5.  Percutaneous transluminal coronary angioplasty--histopathological analysis of nine necropsy cases.

Authors:  C F de Morais; E A Lopes; H Checchi; S Arie; F Pileggi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

6.  Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.

Authors:  A H Gershlick; D Spriggins; S W Davies; Y D Syndercombe Court; J Timmins; A D Timmis; M T Rothman; C Layton; R Balcon
Journal:  Br Heart J       Date:  1994-01

Review 7.  Restenosis following percutaneous transluminal angioplasty: clinical, physiologic and pathological features.

Authors:  J L Cox; A I Gotlieb
Journal:  CMAJ       Date:  1986-05-15       Impact factor: 8.262

8.  Circulating microRNAs as potential biomarkers for coronary plaque rupture.

Authors:  Sufang Li; Chongyou Lee; Junxian Song; Changlin Lu; Jun Liu; Yuxia Cui; Huizhu Liang; Chengfu Cao; Feng Zhang; Hong Chen
Journal:  Oncotarget       Date:  2017-07-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.